Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online December 6, 2022.
Article Versions
- You are currently viewing an Earlier version of this article (December 6, 2022 - 09:04).
- earlier version (February 21, 2023 - 05:25).
- View the most recent version of this article
Copyright & Usage
Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics
Author Information
- Glenn A. Reinhart1,
- Paul C. Harrison2,
- Kathleen Lincoln2,
- Hongxing Chen3,
- Peng Sun4,
- Jon Hill2,
- Hu Sheng Qian3,
- Mark McHugh3,
- Holly Clifford3,
- Khing Jow Ng2,
- Hong Wang2,
- Danielle Fowler2,
- Kristina K. Gueneva-Boucheva5,
- Todd Bosanac6,
- Diane Wong2,
- Ryan M. Fryer7,
- Chris Sarko6,
- Carine M Boustany-Kari3, and
- Steven S. Pullen2,*
- 1Boehringer Ingelheim Pharmaceuticals, United States
- 2Cardiometabolic Diseases Research, Boehringer-Ingelheim Pharmaceuticals, United States
- 3Boehringer Ingelheim Pharmaceuticals, Inc., United States
- 4Cardiometabolic Diseases Research, Boehringer Ingelheim Pharmaceuticals, Inc., United States
- 5DDS, Boehringer-Ingelheim, United States
- 6Small Molecule Discovery Researcy, Boehringer-Ingelheim Pharmaceuticals, United States
- 7Cardiometabolic Diseases Research, Boehringer Ingelheim Pharmaceuticals, Inc, United States
- ↵* Corresponding Author:
Steven S. Pullen, Cardiometabolic Diseases Research, Boehringer-Ingelheim Pharmaceuticals, 900 Ridgebury Road, PO Box 368, Ridgebury, Connecticut, 06877-0368, United States. E-mail: steven.pullen{at}boehringer-ingelheim.com
Statistics from Altmetric.com
Article usage
In this issue
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement